Chiesi, Zymenex deal

Chiesi will acquire Zymenex for an undisclosed amount. Chiesi will gain Zymenex's Lamazym (rhLaman), a recombinant human mannosidase enzyme that is in Phase III testing to treat alpha-mannosidosis, a...